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ABSTRACT
Objectives: The primary objective of the study was to evaluate the link existing between insomnia and low levels of Vitamin D and the secondary 
objective was to confirm a link between age and insomnia.
Methods: The study assessed the Vitamin D serum levels in 50 subjects with insomnia (diagnosed using Pittsburgh Sleep Quality Index [PSQI]) from 
the outpatient clinic, Department of General Medicine of Sri Ramachandra Medical Center. All subjects fulfilled the eligibility criteria and also signed 
the informed consent form provided in patient’s native language for their convenience. With all aseptic precautions, 5 ml of blood was collected from 
the subjects for tyhe measurement of 25-OH Vitamin-D total levels using fully automated chemiluminescent immunoassay. Statistical analysis was 
performed using the Statistical Package for the Social Sciences (SPSS 1 7.1). Quantitative variables will be expressed as mean ± standard deviation 
(SD), and qualitative variables will be expressed as percentage values.
Results: All the patients who are insomniacs were deficient of Vitamin D. Of this, 80% were in deficient state (i.e.,>20 ng/ml) and the rest 20% were 
in the insufficient state (i.e., 20–30 ng/ml). Most of the insomniacs were younger adults. As shown in the graph, 27 patients were in between the 
age group of 20 and 30 years, 13 patients of 50 patients were between 30 and 40 years of age, 4 patients between 40 and 50 years of age, 4 patients 
between 50 and 60 years of age, and 2 patients were of age between 60 and 70 years.
Conclusion: Our results concluded that insomnia has a direct link with Vitamin D deficiency. Male insomniacs who were Vitamin D deficient were 
40% more than female insomniacs with Vitamin D deficiency. It was noted that the incidence of increased body mass index and systolic blood pressure 
was seen among Vitamin D-deficient insomniacs. Insomnia was more prevalent among younger age groups rather than older adults. Global PSQI value 
evaluated among all Vitamin D-deficient patients was >5, which indicated poor sleep quality.
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INTRODUCTION
Insomnia, also known as sleeplessness, is a sleep disorder where 
people have trouble sleeping. They may have difficulty falling asleep or 
staying asleep as long as desired [1,2]. Insomnia is typically followed 
by daytime sleepiness, low energy, irritability, and a depressed mood. 
It may result in an increased risk of motor vehicle collisions, as well as 
problems focusing and learning. Insomnia can be short term, lasting for 
days or weeks, or long term, lasting more than a month.
Insomnia can occur independently or as a result of another problem. 
Conditions that can result in insomnia include psychological stress, 
chronic pain, heart failure, hyperthyroidism, heartburn, restless leg 
syndrome, menopause, certain medications, and drugs such as caffeine, 
nicotine, and alcohol. Other risk factors include working night shifts 
and sleep apnea. Diagnosis is based on sleep habits and an examination 
to look for underlying causes. A sleep study may be done to look for 
underlying sleep disorders. Sleep hygiene and lifestyle changes are 
typically the first treatment for insomnia. Sleep hygiene includes a 
consistent bedtime, exposure to sunlight, a quiet and dark room, and 
regular exercise. While sleeping pills may help, they are associated with 
injuries, dementia, and addiction. Medications are not recommended 
for more than 4 or 5 weeks. The effectiveness and safety of alternative 
medicine are unclear.
Between 10% and 30% of adults have insomnia at any given point in 
time and up to half of the people have insomnia in a given year. About 
6% of people have insomnia that is not due to another problem and 
lasts for more than a month. People over the age of 65 are affected more 
often than younger people. Females are more often affected than males.
Vitamin D deficiency can be caused by a number of factors including 
insufficient cutaneous synthesis (due to limited sunlight exposure or 
aging, inadequate intake and absorption of vitamin D, obesity, or darker 
skin) [3]. Elderly people (due to decreased outdoor activity), individuals 
with darker skin tone (as melanin absorbs ultraviolet radiation), 
and pregnant/lactating women and children are at increased risk of 
Vitamin D deficiency.
Serum 25 (OH) Vitamin D is the major circulating metabolite of 
Vitamin D and reflects Vitamin D inputs from cutaneous synthesis 
and dietary intake. Serum 25 (OH) is the standard clinical measure of 
Vitamin D status [4]. Vitamin D deficiency is defined as a level <20 ng/ml 
and Vitamin D insufficiency is a level <30 ng/ml.
Insomnia maybe due to physical discomfort, psychological factors, and 
fluctuations in metabolic control, and many of these factors are also 
associated with Vitamin D deficiency. Quality of life is affected, and 
coping with the disease is made difficult by insomnia [5].
Vitamin D deficiency subjects have high levels of tumor necrosis 
factor-alpha (TNF-α), an inflammatory marker which is implicated 
in sleepiness associated with obstructive sleep apnea (OSA) [6]. The 
rise in inflammatory marker may also contribute to disturbed sleep in 
some individuals, suggesting the possibility that Vitamin D deficiency 
could represent a condition which predisposes an individual to the 
development of pathological degrees of central nervous system (CNS)-
induced sleep disorder.
Vitamin D plays a major role in the pathogenesis and prevention of 
insomnia. Prevention of Vitamin D deficiency may become, in future, 
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a strategy to prevent the development of insomnia and avoid its 
deleterious consequences on health. It is very important to assess 
the Vitamin D status because the effective detection and treatment of 
inadequate Vitamin D levels are easy and cost-effective therapy which 
could improve individuals sleep pattern which in turn can improve 
long-term health outcomes and quality of life. The aim of the study is to 
assess the Vitamin D serum levels in patients with Insomnia.
METHODS
Study design
This was a prospective, cross-sectional, analytical study
Sample size
The sample size was 50.
Study population
The study assessed the Vitamin D serum levels in 50 subjects with 
insomnia (diagnosed using Pittsburgh Sleep Quality Index [PSQI]) 
from the outpatient clinic, Department of General Medicine of Sri 
Ramachandra Medical Center. All subjects fulfilled the eligibility 
criteria and also signed the informed consent form provided in 
patient’s native language for their convenience. With all aseptic 
precautions, 5 ml of blood was collected from the subjects for the 
measurement of Vitamin-D levels. This study was approved by the 
Ethical Committee.
The following criteria to be met by screened subjects.
Inclusion criteria
• Sex: Both male and female
• Age group: 20–70 years
• Subjects who provided a written informed consent
• Subjects were willing to cooperate with the study procedures.
Exclusion criteria
• Subjects with psychiatric disorders
• Subjects taking psychoactive drugs or stimulants, herbs, nicotine, 
cocaine, amphetamines, methylphenidate, modafinil, fluoroquinolone 
antibiotic drugs.
Laboratory investigations
• Serum 25–OH Vitamin D - Radioimmunoassay (RIA Kit method).
Research tool
In all subjects, quality of sleep was evaluated through the PSQI through 
the interview method. PSQI assesses subjective sleep quality over the 
past 4 weeks. The PSQI is a self-report questionnaire that assesses 
sleep quality and quantity over a 1 month period. The questionnaire 
consisted of 19 self-rated questions and 5 questions that were to 
be answered by bedmates or roommates. The latter questions are 
used only for clinical information and are not used in the scoring. 19 
questions are categorized into 7 components, graded on a score that 
ranges from 0 to 3. The PSQI components are as follows: Subjective 
sleep quality (C1), sleep latency (C2), sleep duration (C3), habitual sleep 
efficiency (C4), sleep disturbances (C5), use of sleeping medication 
(C6), and daytime dysfunction (C7). The sum of scores for these seven 
components yields one global score, which ranges from 0 to 21, where 
the highest score indicates worst sleep quality. A global PSQI ≥5 has a 
diagnostic sensitivity of 89.6 and specificity of 86.5 in distinguishing 
“poor sleepers” (PSQI ≥5) from “good sleepers” (PSQI <5) subjects. The 
design of the PSQI is such that the items and the component scores 
represent standard areas that clinicians usually focus on when patients 
report sleep problems.
Statistical analysis
A statistical analysis was performed using the SPSS 1 7.1. Quantitative 
variables will be expressed as mean ± SD, and qualitative variables will 
be expressed as percentage values.
RESULTS
All the patients who are insomniacs were deficient of Vitamin D. Of this, 
80% were in deficient state (i.e., >20 ng/ml) and the rest 20% were 
in insufficient state (i.e., 20–30 ng/ml). Most of the insomniacs were 
younger adults. As shown in the graph, 27 patients were in between the 
age group of 20 and 30 years, 13 patients of 50 patients were between 
30 and 40 years of age, 4 patients between 40 and 50 years of age, 
4 patients between 50 and 60 years of age, and 2 patients were of age 
between 60 and 70 years.
All the patients who are insomniacs were deficient of Vitamin D. Of this, 
80% were in deficient state (i.e., >20 ng/ml) and the rest 20% were in 
insufficient state (i.e., 20–30 ng/ml).
Most of the insomniacs were younger adults. As shown in the graph, 
27 patients were in between the age group of 20 and 30 years, 
13 patients of 50 patients were between 30 and 40 years of age, 
4 patients between 40 and 50 years of age, 4 patients between 50 and 
60 years of age, and 2 patients were of age between 60 and 70 years.
Most of the patients take more than 1 h to fall asleep from the time of 
them going to bed. 30 of our patients took more than 60 min and 16 of 
them took 31–60 min, 4 patients between 16 and 30 min, and none fell 
asleep <15 min.
DISCUSSION
A total of 50 patients were assessed, and all the patients met the 
inclusion and exclusion criteria set for the study.
According to Verdoia et al. and Shiva Fajahih, lower Vitamin D levels are 
observed in females as compared to males [7]. This is in contrast to our 
study where lower Vitamin D levels are observed in males as compared 
to females (Fig. 1). This may be because most of the male patients these 
days are involved in sedentary occupations such as IT professionals, 
teachers, students, and housewife which prevent them from sun 
exposure because sunlight is the most common source of Vitamin D.
In our study, Vitamin D levels were markedly decreased in patients 
suffering from insomnia.All the 50 patients we assessed had Vitamin D 
deficiency. Of this, 80% are in deficient state (i.e., >20 ng/ml) and the 
rest 20% are in insufficient state (i.e., 20–30 ng/ml) (Fig. 2).
The sleep quality was evaluated using the PSQI. As of the PSQI 
grading, a score of 5 or >5 is indicative of poor sleep quality. All 
the 50 patients (Fig. 8) who were assessed had a total PSQI score >6, 
Fig. 1: Percentage of Vitamin D deficiency in males and females 
having insomnia. In this study, male insomniacs who were 
Vitamin D deficient were 70% i.e., of 50 patients, 35 patients were 
males, whereas only 15 patients were females
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Fig. 2: Vitamin D levels in insomnia patients
Fig. 3: Relation between age and incidence of insomnia
Fig. 4: Body mass index (BMI) and percentage of patients with 
insomnia having Vitamin D deficiency. With increasing BMI, a 
decrease in Vitamin D serum levels is observed in insomniacs. 
12 patients were in the category of underweight, i.e., <18.5 BMI, 
11 patients belonged to normal weight category, and 17 and 19 were 
under overweight and obese categories, respectively
Fig. 5: Linear graph representing the relation between systolic 
blood pressure and the number of patients with insomnia having 
Vitamin D deficiency. Insomniacs with Vitamin D deficiency tend 
to have increased systolic blood pressure
Fig. 6: Area graph plotting the number of insominic patients and 
their time of going to bed. The maximum number of patients 
goes to sleep by 10:00 PM (11 patients of 50). A slight increase 
(8 patients) is seen around 8:00 PM also
suggesting that all our patients are insomniacs (Fig. 7). A greater global 
PSQI score may mean that the person takes a longer time to fall asleep 
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or may indicate waking very early. A greater score can also mean that 
sleep is fragmented and restless, with many awakenings throughout the 
night (Table 1) [8,9].
Multiple factors likely contribute to poor sleep quality in Vitamin D 
deficiency subjects. Vitamin D has a direct neuroregulatory activity. 
Vitamin D receptor (VDR) and 25 (OH) D3 1, a hydroxylase (catalyzes 
hydroxylation of calcidiol to calcitriol) are widely distributed 
throughout CNS. VDR gene polymorphisms have been associated with 
cognitive impairment and depressive symptoms which in turn are 
associated with poor sleep quality [10,11]. Further, Vitamin D is a potent 
biologic regulator of prostaglandin synthesis, the major prostanoid in 
the brain, and is the physiologic regulator of sleep. Vitamin D-deficient 
individuals have low levels of prostaglandin D2 which is attributed to 
poor sleep outcomes.
The immunomodulatory effect of Vitamin D has been related to recent 
evidence that inflammation may play a causal role in altered sleep 
pattern; Vitamin D has been shown to downregulate inflammatory 
mediators, such as nuclear factor-kB, which have been linked to 
sickness behavior, psychosocial stress, and depression.
Vitamin D deficiency subjects have high levels of TNF-α, an inflammatory 
marker that is implicated in sleepiness associated with OSA. The rise in 
inflammatory marker may also contribute to disturbed sleep in some 
individuals, suggesting the possibility that Vitamin D deficiency could 
represent a condition which predisposes an individual to the development 
of pathological degrees of CNS-induced sleep disorder. Insomnia observed 
in individual with low Vitamin D levels is possible due to physical and 
physiological discomfort associated with Vitamin D deficiency.
Observing the graph plotted with age and incidence of insomnia (Fig. 3), 
most of the insomniacs were younger adults. As shown in the graph, 27 
of our patients were in between the age group of 20 and 30, 13 of 50 
were between 30 and 40, 4 between 40 and 50 years of age, 4 between 
50 and 60 years of age also, and 2 between 60 and 70 years. This is 
due to the increased usage of social media in which many younger 
adults have even become addicted to it in such a way that they are sleep 
deprived. Other reason would be the professional and financial stress.
This is in contrast with the results by Zhang et al. and Roth, and in their 
studies, incidence of insomnia was increased with age [12,13]. The 
possible explanations given by them were that older adults experience 
a shift in the circadian rhythm that causes them to become sleepy in the 
early evening and to wake up too early in the morning. Other reasons 
would be like the medical conditions and other sleep disorders of the 
elderly, which can also cause insomnia. For example, health issues such 
as gastrointestinal and respiratory problems can disrupt sleep. Sleep 
apnea - in which a person briefly but repeatedly stops breathing during 
sleep - can also cause insomnia. 
According to Vanlint and Jacobo Wartzman, obese subjects had 
significantly lower basal 25-hydroxyvitamin D concentrations 
compared to non-obese, which correlated with our results [14,15]. With 
increasing body mass index (BMI), a decrease in Vitamin D serum levels 
was observed in our study samples. 12 patients were in (Fig. 4) the 
category of underweight, i.e., <18.5 BMI, 11 patients belonged to normal 
weight category and 17 and 19 patients under overweight and obese 
categories, respectively. This is because Vitamin D is fat-soluble and is 
readily stored in adipose tissue, it could be sequestered in the larger 
body pool of fat in obese individuals. It can also be due to lower dietary 
intake, reduced activation, or increased catabolism. Another possibility 
is that obese individuals usually follow a sedentary lifestyle which 
rarely exposes them to sunlight than non-obese individuals, resulting 
in reduced synthesis of Vitamin D. However, these findings were in 
contrast with the findings of Zam where he explained obesity to be 
inversely related to Vitamin D level [16].
According to Li et al. and David et al., insomnia-induced hypertension 
is very common. This is similar to our study where the insomniacs with 
Vitamin D deficiency tend to have increased systolic blood pressure. 
27 of 50 patients had a systolic blood pressure of 150 mmHg or 
greater (Fig. 5). None had a systolic blood pressure <120 mmHg. As 
concluded in the above-mentioned studies, this is due to the activation 
of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous 
system as seen in insomnia [17,18].
Time at which the patients go to sleep was noted, and it is seen that the 
maximum number of patients goes to sleep by 10:00 PM (11 patients 
of 50) (Fig. 6). Strangely, a slight increase (8 patients) is seen around 
8:00 PM also. Time taken to fell asleep was also noted where most of 
the patients take more than 1 h to fell asleep from the time of them 
going to bed. 30 of our patients took more than 60 min and 16 of them 
took 31–60 min, 4 patients between 16 and 30 min, and none fall asleep 
<15 min. The delayed time to go to bed and the increased time to fell 
asleep can be again correlated with the use of mobile phones among 
young adult during bedtime.
Fig. 7: Time taken to fall asleep by the insomniacs
Fig. 8: Marked line graph depicting global Pittsburgh Sleep 
Quality Index (PSQI) score and the corresponding number of 
patients. As of the PSQI grading, a score of 5 or >5 is indicative 
of poor sleep quality. All the 50 patients who were assessed 
had a total PSQI score >6, suggesting that all our patients are 
insomniacs
Table 1: Various causes for trouble sleeping and the number of 
patients experiencing such problems
Causes for trouble sleeping Number of 
patients
1. Wake up in the middle of the night or early morning 50
2. Have to get up to use the bathroom 50
3. Cough or snore loudly 08
4. Feel too cold or hot 07
5. Have bad dreams 18
6. Have pain 05
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CONCLUSION
Our results concluded that insomnia has a direct link with Vitamin D 
deficiency. Male insomniacs who were Vitamin D deficient were 40% 
more than female insomniacs with Vitamin D deficiency. It was noted 
that the incidence of increased BMI and systolic blood pressure was 
seen among Vitamin D-deficient insomniacs. Insomnia was more 
prevalent among younger age groups rather than older adults. Global 
PSQI value evaluated among all Vitamin D-deficient patients was >5, 
which indicated poor sleep quality.
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